STAT

STAT+: Pharmalittle: Ohio attorney general accuses PBMs of price fixing; how cost-effectiveness fight could hobble drug price negotiations

Congressional Republicans are scrambling to bar use of a quality-of-life metric, a push Democrats argue could hobble Medicare drug-price negotiations.
Source: Alex Hogan/STAT

Top of the morning to you. Steely gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Pfizer Drug For Duchenne, Bird Flu Vaccines For Cows, And More
Pfizer reported that its gene therapy for Duchenne muscular dystrophy failed to slow disease progression in a Phase 3 trial.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Sanders Dogging Novo Nordisk, Teva Patents, And More
U.S. Senate health committee chair Bernie Sanders called a vote to subpoena the chief of Novo Nordisk’s U.S. division over pricing of Ozempic and Wegovy.
STAT1 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Alzheimer’s Drug, The GSK-Elsie Deal, And More
In today's Pharmalittle roundup, we're reading about Eli Lilly's Alzheimer's drug, the GSK-Elsie deal, and more.

Related Books & Audiobooks